Antimicrobial-associated risk factors for Clostridium difficile infection. - Wikidata - thesis-toulmin - TriplyDB

Antimicrobial-associated risk factors for Clostridium difficile infection.

Antimicrobial-associated risk factors for Clostridium difficile infection.

http://www.wikidata.org/entity/Q37051298

about

Probiotics for the prevention of pediatric antibiotic-associated diarrhea Probiotics for the prevention of pediatric antibiotic-associated diarrhea Efflux-mediated drug resistance in bacteria: an update Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Experimental design considerations in microbiota/inflammation studies Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance Interactions Between the Gastrointestinal Microbiome and Clostridium difficile WSES guidelines for management of Clostridium difficile infection in surgical patients The application of ecological theory toward an understanding of the human microbiome Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease Laboratory diagnosis of bacterial gastroenteritis Unnecessary use of fluoroquinolone antibiotics in hospitalized patients The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection Proton pump inhibitors alter the composition of the gut microbiota [Clostridium difficile infections in geriatric patients].Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.Antimicrobial stewardship: philosophy versus practice.Immune responses to Clostridium difficile infection Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections Use of data envelopment analysis to quantify opportunities for antibacterial targets for reduction of health care-associated Clostridium difficile infection.Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium The management of acne vulgaris in pregnancy.Prevalence of inappropriate antibiotic prescriptions after the great east Japan earthquake, 2011.Hematologic diseases: high risk of Clostridium difficile associated diarrhea Identification and characterization of a gene cluster required for proper rod shape, cell division, and pathogenesis in Clostridium difficile.Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options.Assessing control bundles for Clostridium difficile: a review and mathematical model Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.Antimicrobial prescribing in hospitalized adults stratified by age: data from the ESAC point-prevalence surveys.Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan A selective antibiotic prophylaxis policy for laparoscopic cholecystectomy is effective in minimising infective complications.Microbiota-mediated colonization resistance against intestinal pathogens.The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.Risk Factors for the Development of Clostridium difficile-associated Colitis after Colorectal Cancer Surgery

P2860

Q24186991-40C38917-38A2-492C-8B9F-006B3D1D2FD0 Q24235039-BFAEE5C8-1457-444D-A5CC-DBC41AB9B1B9 Q24609407-869C88A0-1099-4C4C-AA47-26A1EFFB7EB3 Q24614464-D8AE762A-C1B1-405F-A4AA-96882851ABA3 Q24632307-03283374-E0F5-46D1-94CE-071D368A5A16 Q26739860-7B4959EE-09D2-480F-BE9F-9D570C7EB4E4 Q26741486-82DAED0E-B3C2-4634-BF72-CF4365EEF5B4 Q26771942-CFD71DEC-3557-4472-BC7C-557E8C438C52 Q26771995-E8D4735B-D916-4C29-A1DF-82F41A1A906F Q26778722-6B3192A3-5D8E-4DD0-AF28-348A1700838A Q26795429-6DCE5F10-E2F2-4717-983C-EAAF9F508EE8 Q26825590-3C873893-A06C-4DA8-8610-7EF05C47750A Q26851409-7DC6239C-6854-4165-AD92-A2836108470F Q27027754-6F1115D7-83E8-4D96-8A81-72543EC46411 Q27496669-CCD40F57-247F-42B3-899C-4E229F6CB62B Q28075770-B093F2A6-4C41-4471-ADB8-E035968BF4C7 Q28084026-5455B757-B57D-4F99-9831-763710E7D9A6 Q28603378-10C2A5EA-18F8-49FB-896C-08229C1C83CE Q30244040-C2EC9463-98D9-400F-9D16-3995FB8451E4 Q30277636-8EC4A6FC-DCD4-44DF-B756-5EF747309CE1 Q30367226-8BD6717B-499C-42FE-BE09-370B452E8458 Q30416692-1D0BA31C-479E-4ADC-A601-87A671EC4788 Q30433267-6661F402-66F7-473A-BF65-BA8A1BB06CE1 Q30666603-0E827E0D-914E-4EDD-B47B-2B88A2C34EC6 Q30834661-3CC65C28-FBD6-455F-8A43-182114376D2A Q30850682-62216754-9555-4E97-8640-01A4C5B92C64 Q31135745-5312609E-B9F9-4D37-ACBC-8C6211CE9BF9 Q33597407-759D45AF-5FD8-49F5-ABB2-F81A29B57872 Q33718326-DB2CA533-E743-4F6E-B13E-67B19264AF23 Q33743243-ED5FBFCE-F220-4CF2-9DCE-D8C96AA4B8AC Q33759832-C592E535-9945-43A1-B55D-FD62BFA364DA Q33834926-A901B474-F2DD-4EDC-83BD-1BCE3545BC29 Q33887897-61FFA9A9-7E2B-40FB-B72E-F67C0FC3E998 Q34046334-64340048-B4FB-475D-8E3E-CBCD3D5986D6 Q34108743-D6BF5986-1D37-425C-A1AF-3BF49DBE19D5 Q34151774-F503C0B4-14E1-428E-AD3C-6D6C187A43E8 Q34192625-766301F1-4B31-4E19-8DBA-D52EF4830A76 Q34324937-D10A7A13-6FE2-4595-879E-0D08A8D6DCFE Q34325764-4F1AE8B6-E7F2-489D-A1BF-097570DBFDB7 Q34385353-465E9680-B18A-4CC7-B30C-FEF63219C080

P2860

Antimicrobial-associated risk factors for Clostridium difficile infection.

http://www.wikidata.org/entity/Q37051298

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antimicrobial-associated risk factors for Clostridium difficile infection.

@en

Antimicrobial-associated risk factors for Clostridium difficile infection.

@nl

type

label

Antimicrobial-associated risk factors for Clostridium difficile infection.

@en

Antimicrobial-associated risk factors for Clostridium difficile infection.

@nl

prefLabel

Antimicrobial-associated risk factors for Clostridium difficile infection.

@en

Antimicrobial-associated risk factors for Clostridium difficile infection.

@nl

P1433

Q37051298-8DBDD232-E6A3-48A0-8C42-0B3D9D66FAD8

P1476

Q37051298-D5FB372C-1BD9-4AA0-9200-77928C17B4AF

P2093

Q37051298-23AC938A-A1E0-49E3-AA22-3D0A4C87823F

Q37051298-45621040-CFDA-4EA8-9757-C3F63E59027E

Q37051298-4A7F169E-F9EF-4BBF-A3C8-A1848A0FCA59

Q37051298-B6287E65-628F-446E-B931-B4596815BF45

P2860

Q37051298-05E30B73-16AB-454E-A22A-60641743D4EF

Q37051298-0AA2C202-187B-4EA4-A63E-50F0AC37D4D8

Q37051298-0B454176-B81C-4085-A671-F8AD7EE243A1

Q37051298-12FD2230-2E2F-4A09-A34C-AACE55070562

Q37051298-185DC74D-7845-4C32-A9E8-585BFB4AA12A

Q37051298-21EBDE57-FB6E-4430-9928-2590D8FDD414

Q37051298-24710C2B-DF07-4294-8D09-F9143C25C83C

Q37051298-25E16AD1-896A-4BA6-99D9-D63EC248A906

Q37051298-293D6949-1D28-4A7E-9842-11C4D6181317

Q37051298-3311ECD3-5FD0-4780-A45C-FB2D20683C05

P304

Q37051298-2432D8E5-332A-48E4-9EA6-DD837E458750

P31

Q37051298-49523AD0-D897-4AEA-98B6-1E36343614CC

P356

Q37051298-0F9A8B90-0E84-4F3F-966B-5B7E4DB3F495

P407

Q37051298-B922CCB5-D018-4F07-8DC1-93CB88AD61E6

P478

Q37051298-DD9422FC-C91A-4FB3-8A8E-4E6612206CF9

P50

Q37051298-A0B45BF6-4F92-41BA-B3C9-19D02531DDC2

P577

Q37051298-137B31C7-CF17-4F24-AD44-7B156B513C2E

P5875

Q37051298-3F8F83FD-5692-4892-8F29-624F219CAA95

P698

Q37051298-10650C25-6EB4-4ECF-84F7-89B6F2216723

P921

Q37051298-58D1305B-00B2-4A41-B386-A7E3C3C9BF3C

P356

P1433

Clinical Infectious Diseases

P1476

Antimicrobial-associated risk factors for Clostridium difficile infection.

@en

P2093

Carlene A Muto

http://www.w3.org/2001/XMLSchema#string

Robert C Owens

http://www.w3.org/2001/XMLSchema#string

Robert P Gaynes

http://www.w3.org/2001/XMLSchema#string

Vivian G Loo

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of linezolid against Clostridium difficile.

Monitoring of stool microbiota in subjects with diarrhea indicates distortions in composition

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Fluoroquinolone prescribing in the United States: 1995 to 2002.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

An epidemic, toxin gene-variant strain of Clostridium difficile.

P304

S19-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/521859

http://www.w3.org/2001/XMLSchema#string

P407

P478

46 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Curtis J Donskey

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5673416

http://www.w3.org/2001/XMLSchema#string

P698

18177218

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile